Document is current

Article History

Received: 13 March 2025

Accepted: 22 May 2025

First Online: 17 July 2025

Declarations

:

: Luis Puig has received honoraria or fees for serving on advisory boards, as a speaker, and as a consultant, as well as grants as an investigator from AbbVie, Almirall, Amgen, Baxalta, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Fresenius-Kabi, Janssen, JS BIOCAD, LEO Pharma, Lilly, Mylan, Novartis, Pfizer, Regeneron, Roche, Sandoz, Samsung-Bioepis, Sanofi, and UCB. Philipp Sewerin is a paid consultant for AXIOM Health, AMGEN, AbbVie, Astra Zeneca, Biogen, Bristol Myers Squibb, Boehringer Ingelheim, Celgene, Celltrion, Chugai Pharma Marketing Ltd, Deutscher Psoriasis-Bund, Fresenius Kabi, Gilead Sciences, Galapagos Pharma, Hexal Pharma, Janssen-Cilag, Johnson & Johnson, Lilly, medi-login, Medac, Mediri GmbH, Novartis Pharma, Onkowissen GmbH, Pfizer, Roche Pharma, Rheumazentrum RheinRuhr, Sanofi-Genzyme, Swedish Orphan Biovitrum, and UCB Pharma. He serves on the advisory board of AMGEN, AbbVie, Biogen, Bristol Myers Squibb, Gilead Sciences, Hexal Pharma, Janssen-Cilag, Johnson & Johnson, Lilly, Mediri GmbH, Novartis Pharma, Onkowissen GmbH, Pfizer, Roche Pharma, Sanofi-Genzyme, and UCB Pharma. Christopher Schuster is an employee and a minor stakeholder of Eli Lilly and Company. Khai Jing Ng is an employee and minor stakeholder of Eli Lilly and Company. Manny Papadimitropoulos is an employee and minor stakeholder of Eli Lilly and Company. Sneha Gadagamma is an employee and minor stakeholder of Eli Lilly and Company. Mercedes Nuñez is an employee and minor stakeholder of Eli Lilly and Company. Anastasia Lampropoulou was an employee and minor stakeholder of Eli Lilly and Company at the time the work was conducted.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.